PT92368A - Processo para a preparacao de novas quinuclidinas e de composicoes farmaceuticas que as contem - Google Patents
Processo para a preparacao de novas quinuclidinas e de composicoes farmaceuticas que as contemInfo
- Publication number
- PT92368A PT92368A PT92368A PT9236889A PT92368A PT 92368 A PT92368 A PT 92368A PT 92368 A PT92368 A PT 92368A PT 9236889 A PT9236889 A PT 9236889A PT 92368 A PT92368 A PT 92368A
- Authority
- PT
- Portugal
- Prior art keywords
- quinuclidines
- pharmaceutical compositions
- compositions containing
- preparing new
- preparing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3839385A DE3839385A1 (de) | 1988-11-22 | 1988-11-22 | Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
PT92368A true PT92368A (pt) | 1990-05-31 |
PT92368B PT92368B (pt) | 1995-07-18 |
Family
ID=6367625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT92368A PT92368B (pt) | 1988-11-22 | 1989-11-21 | Processo para a preparacao de novas quinuclidinas e de composicoes farmaceuticas que as contem |
Country Status (18)
Country | Link |
---|---|
US (2) | US5451587A (pt) |
EP (1) | EP0370415B1 (pt) |
JP (1) | JPH0686449B2 (pt) |
KR (1) | KR0165667B1 (pt) |
AU (1) | AU628884B2 (pt) |
BG (1) | BG61859B2 (pt) |
CA (1) | CA2003422C (pt) |
DE (3) | DE3839385A1 (pt) |
DK (1) | DK170167B1 (pt) |
ES (1) | ES2054988T3 (pt) |
FI (1) | FI91637C (pt) |
HU (1) | HU202527B (pt) |
IE (1) | IE62328B1 (pt) |
IL (1) | IL92377A (pt) |
NO (1) | NO172801C (pt) |
NZ (1) | NZ231445A (pt) |
PT (1) | PT92368B (pt) |
ZA (1) | ZA898858B (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
EP0492904A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted benzene derivatives for use in the treatment of glaucoma |
EP0492903A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
EP0492902A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyridine derivatives for use in the treatment of glaucoma |
ZA92278B (en) * | 1991-02-01 | 1992-10-28 | Akzo Nv | 3-quinuclidine derivatives |
GB9122988D0 (en) * | 1991-10-30 | 1991-12-18 | Ici Plc | Heterocyclic compounds |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
AU3901393A (en) * | 1992-04-10 | 1993-11-18 | Zeneca Limited | Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
GB9211796D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Heterocyclic derivatives |
GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
DE4236331A1 (de) * | 1992-10-28 | 1994-05-05 | Boehringer Ingelheim Kg | Synergistische Kombination |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5512574A (en) * | 1994-12-21 | 1996-04-30 | American Home Products Corporation | Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists |
DK0785198T3 (da) | 1996-01-19 | 2000-11-13 | Lonza Ag | Fremgangsmåde til fremstilling af optisk aktiv 3-quinuclidinol |
SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
CZ54498A3 (cs) * | 1997-03-07 | 1998-11-11 | Lonza Ag | Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití |
AU6896098A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Method for treating schizophrenia |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
DE10106971A1 (de) * | 2001-02-15 | 2002-08-29 | Boehringer Ingelheim Pharma | Arzneimittelformulierung die einen muskarinischen Agonisten enthält |
KR100448002B1 (ko) * | 2002-02-01 | 2004-09-13 | 한국과학기술연구원 | 신규한 퀴누클리딘 화합물 및 그 제조방법 |
KR20030083289A (ko) * | 2002-04-20 | 2003-10-30 | 한승호 | 다공질 화분 |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
EP1928437A2 (en) * | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2014831A1 (en) * | 1968-08-01 | 1970-04-24 | Sogeras | Quinuclidinyl and quinuclidinylalkyl ethers with cholino - lytic, antihistaminic and neurosedative activity |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-11-22 DE DE3839385A patent/DE3839385A1/de not_active Withdrawn
- 1988-11-22 DE DE8817121U patent/DE8817121U1/de not_active Expired - Lifetime
-
1989
- 1989-11-18 DE DE8989121387T patent/DE58904567D1/de not_active Expired - Lifetime
- 1989-11-18 EP EP89121387A patent/EP0370415B1/de not_active Expired - Lifetime
- 1989-11-18 ES ES89121387T patent/ES2054988T3/es not_active Expired - Lifetime
- 1989-11-20 KR KR1019890016802A patent/KR0165667B1/ko not_active IP Right Cessation
- 1989-11-20 NZ NZ231445A patent/NZ231445A/xx unknown
- 1989-11-21 CA CA002003422A patent/CA2003422C/en not_active Expired - Lifetime
- 1989-11-21 HU HU896032A patent/HU202527B/hu unknown
- 1989-11-21 ZA ZA898858A patent/ZA898858B/xx unknown
- 1989-11-21 DK DK584089A patent/DK170167B1/da not_active IP Right Cessation
- 1989-11-21 PT PT92368A patent/PT92368B/pt not_active IP Right Cessation
- 1989-11-21 JP JP1303037A patent/JPH0686449B2/ja not_active Expired - Lifetime
- 1989-11-21 IL IL9237789A patent/IL92377A/en not_active IP Right Cessation
- 1989-11-21 IE IE371289A patent/IE62328B1/en not_active IP Right Cessation
- 1989-11-21 FI FI895531A patent/FI91637C/fi active IP Right Grant
- 1989-11-21 NO NO894630A patent/NO172801C/no not_active IP Right Cessation
- 1989-11-22 AU AU45403/89A patent/AU628884B2/en not_active Expired
-
1994
- 1994-02-18 BG BG98490A patent/BG61859B2/bg unknown
- 1994-05-12 US US08/241,517 patent/US5451587A/en not_active Expired - Lifetime
-
1995
- 1995-06-16 US US08/491,463 patent/US5508405A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT92368A (pt) | Processo para a preparacao de novas quinuclidinas e de composicoes farmaceuticas que as contem | |
PT89009A (pt) | Processo para a preparacao de novos derivados de fluorocitidina e composicoes farmaceuticas que os contem | |
PT84149B (pt) | Processo para a preparacao de novas tieno-1,4-diazepinas e de composicoes farmaceuticas que as contem | |
PT87913A (pt) | Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem | |
PT81746B (pt) | Processo para a preparacao de peptido-aldeidos e de composicoes farmaceuticas que os contem | |
PT89328A (pt) | Processo para a preparacao de novos derivados da adenosina e de composicoes farmaceuticas que os contem | |
PT84569B (pt) | Processo para a preparacao de tiazepinas e de composicoes farmaceuticas que os contem | |
PT78732A (pt) | Processo para a preparacao de 13 alpha-alquilgonanos e de composicoes farmaceuticas que os contem | |
PT93079A (pt) | Processo para a preparacao de composicoes farmaceuticas que contem ciclosporinas | |
PT87201A (pt) | Processo para a preparacao de novos derivados de cefalosporina 3,7-substituida e de composicoes farmaceuticas que os contem | |
PT81650B (pt) | Processo para a preparacao de novas pteridinas e de composicoes farmaceuticas que as contem | |
PT88203A (pt) | Processo para a preparacao de quinolonas e de composicoes farmaceuticas que as contem | |
PT89655A (pt) | Processo para a preparacao de novas lactamas substituidas e de composicoes farmaceuticas que as contem | |
PT93060A (pt) | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem | |
PT80246B (pt) | Processo para a preparacao de novos derivados de cefalosporina e de composicoes farmaceuticas que os contem | |
PT81659B (pt) | Processo para a preparacao de aminoacil-labdanos e de composicoes farmaceuticas que os contem | |
PT80794B (pt) | Processo para a preparacao de novas isoindolinil-alquilpiperazinas e de composicoes farmaceuticas que as contem | |
PT82984B (pt) | Processo para a preparacao de derivados de poli-4-aminopirrole-2-carboxamido e de composicoes farmaceuticas que os contem | |
PT91870A (pt) | Processo para apreparacao de novas quinoliloxazol-2-onas e de composicoes farmaceuticas que as contem | |
PT84358B (pt) | Processo para a preparacao de naftotiazepinonas e de composicoes farmaceuticas que as contem | |
PT89234A (pt) | Processo para a preparacao de novos compostos de amonio e de composicoes farmaceuticas que os contem | |
PT94902A (pt) | Processo para a preparacao de novos derivados de cromano e de composicoes farmaceuticas que os contem | |
PT93138A (pt) | Processo para a preparacao de novos compostos derivados da acetamina e de composicoes farmaceuticas que os contem | |
PT87115A (pt) | Processo para a preparacao de derivados da dihidropiridazinona e de composicoes farmaceuticas que os contem | |
PT87090A (pt) | Processo para a preparacao de derivados de imidazopiridinas e de composicoes farmaceuticas que os contem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20100303 |